Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S66-9. doi: 10.1016/j.jaad.2015.07.040.

Abstract

Pyoderma gangrenosum, severe acne, and suppurative hidradenitis (PASH) syndrome can prove refractory to treatment and is characterized by relapses and recurrences. The combination of antibiotic therapy and surgery can produce success in the management of the syndrome. Acute treatment is required, but maintenance therapy is also necessary to prevent disease relapse. The response to antibiotic therapy is hypothesis generating, raising the issue of a modified host response. To date, anecdotal reports support the use of surgery and medical therapy, but controlled investigations with extended follow-up are necessary to substantiate preliminary data observed with individual cases.

Keywords: PASH syndrome; acne fulminans; antibiotic therapy; hidradenitis suppurativa; microbiome host disease; pyoderma gangrenosum; remission; severe acne.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acne Vulgaris / complications
  • Acne Vulgaris / diagnosis
  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / surgery
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Combined Modality Therapy
  • Drug Delivery Systems / methods*
  • Female
  • Follow-Up Studies
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / diagnosis
  • Hidradenitis Suppurativa / drug therapy*
  • Hidradenitis Suppurativa / surgery
  • Humans
  • Male
  • Microbiota / drug effects
  • Pyoderma Gangrenosum / complications
  • Pyoderma Gangrenosum / diagnosis
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / surgery
  • Sampling Studies
  • Severity of Illness Index
  • Skin / drug effects
  • Skin / microbiology
  • Syndrome
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents